Tabak, Fehmi

Publishing since 1997 (Senior)

Has published 58 publications in 14 years

Number of publications published per year by Tabak, Fehmi. (Source : PubMed)

Distribution of publications types for Tabak, Fehmi. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Ozaras R, Polat E, Aygun G, Yemisen M, Mete B, Goksugur N, Tabak F. A family with skin lesions.  Neth J Med  2010;68;1  
•  Tahan V, Ozaras R, Karaca C, Uraz S, Eren F, Danalioglu A, Avsar E, Turkoglu S, Midilli K, Tabak F, Ozturk R, Mert A, Senturk H, Tozun N. Is HCV genotyping cost-effective even when the prevalences of genotypes 2 and 3 are low?  Hepatogastroenterology  2009;56;94-95  
•  Senturk H, Tabak F, Ozaras R, Erdem L, Canbakan B, Mert A, Yurdakul I. Efficacy of pre-S-containing HBV vaccine combined with lamivudine in the treatment of chronic HBV infection.  Dig. Dis. Sci.  2009;54;9  
•  Tabak F, Gunduz F, Tahan V, Tabak O, Ozaras R. Sertraline hepatotoxicity: report of a case and review of the literature.  Dig. Dis. Sci.  2009;54;7  
•  Ar MC, Ozbalak M, Tuzuner N, Bekoz H, Ozer O, Ugurlu K, Tabak F, Ferhanoglu B. Severe bone marrow failure due to valganciclovir overdose after renal transplantation from cadaveric donors: four consecutive cases.  Transplant. Proc.  2009;41;5  
•  Ozaras R, Ipekci S, Kumbasar H, Aybar Y, Tahan V, Mert A, Ozturk R, Tabak F. Does the presence of peripheral and intra-abdominal lymphadenopathy predict the etiology of acute hepatitis?  J. Clin. Gastroenterol.  2009;43;2  
•  Ozer O, Eskazan AE, Ar MC, Beköz H, Tabak F, Ongen G, Ferhanoglu B. Sarcoidosis mimicking lymphoma on positron emission tomography-computed tomography in two patients treated for lymphoma: two case reports.  Journal of medical case reports  2009;3  
•  Tabak F, Hakko E, Mete B, Ozaras R, Mert A, Ozturk R. Is family screening necessary in brucellosis?  Infection  2008;36;6  
•  Ozaras R, Tabak F, Tahan V, Ozturk R, Akin H, Mert A, Senturk H. Correlation of quantitative assay of HBsAg and HBV DNA levels during chronic HBV treatment.  Dig. Dis. Sci.  2008;53;11  
•  Buster EH, Flink HJ, Cakaloglu Y, Simon K, Trojan J, Tabak F, So TM, Feinman SV, Mach T, Akarca US, Schutten M, Tielemans W, van Vuuren AJ, Hansen BE, Janssen HL. Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b.  Gastroenterology  2008;135;2  

[ See timeline ] [ See all publications ]